Thromb Haemost 1977; 37(02): 262-273
DOI: 10.1055/s-0038-1649227
Original Article
Schattauer GmbH

The Stability of Glutardialdehyde-Stabilized 35-Heparinized Surfaces in Contact with Blood

R. L Larsson
*   Aminkemi AB, Karolinska sjukhuset, Stockholm, Sweden.
,
M.-B Hjelte
*   Aminkemi AB, Karolinska sjukhuset, Stockholm, Sweden.
,
J. C Eriksson
**   Department of Physical Chemistry, Institute of Technology, Karolinska sjukhuset, Stockholm, Sweden.
,
H. R Lagergren
***   Surgical Research Laboratory, Thoracic Clinics, Karolinska sjukhuset, Stockholm, Sweden.
,
P Olsson
***   Surgical Research Laboratory, Thoracic Clinics, Karolinska sjukhuset, Stockholm, Sweden.
› Author Affiliations
Further Information

Publication History

Received 18 May 1975

Accepted 30 September 1976

Publication Date:
03 July 2018 (online)

Summary

Heparin can be bound to polymer surfaces by precipitation of an ionic heparin-amine complex which can be stabilized against dissolution by treatment with glutardialdehyde. The aim of this investigation was to study the degree and course of desorption of heparin from such a heparinized surface on contact with blood. This desorption must be considered when analysing the interaction between the heparinized surface and blood. Different heparinized surfaces were prepared by using 35S-labelled heparin, and the desorption of heparin on exposure in vitro to citrated plasma or heparinized blood as well as during exposure at in vivo conditions was quantified.

During in vitro experiments, the glutardialdehyde stabilized surface became stable with no further desorption of heparin after an initial loss of about 3% of the initial surface-bound heparin. Under in vivo conditions, there was an initial loss of about 12%. There was no further loss from surfaces inserted into the circulation of the dog for seven days as compared to those inserted for one hour.

 
  • References

  • 1 Andersson L. O, Borg H, Miller-Andersson M. Purification and characterization of human factor IX. Thrombosis Research 1975; 7: 451
  • 2 Bergström K, Blombäck B, kleen G. Studies on the plasma fibrinolytic activity in the case of liver cirrhosis. Acta Medica Scandinavica 1960; 168: 291
  • 3 Bruck S. D, Rabin S, Ferguson R. J. Evaluation of biocompatible materials. Biomaterials, Medical Devices, and Artificial Organs 1973; 1: 191
  • 4 Chawla A. S, Chang T. M. S. Non-thrombogenic surface by radiation grafting of heparin Preparation, in vitro and in vivo studies. Biomaterials, Medical Devices, and Artificial Organs 1974; 2: 157
  • 5 Danishefsky I, Tzeng F. Preparation of heparin-linked agarose and its interaction with plasma. Thrombosis Research 1974; 4: 237
  • 6 Eika C, Godal H. C, Kierulf P. Detection of small amounts of heparin by the thrombin clotting-time. Lancet 1972; II: 376
  • 7 Eriksson J. C, Lagergren H, Olsson P, Rådegran K, Swedenborg J, Eldh P, Jacobsson B, Schlossman D, Hjelte M.-B, Larsson R, Rosengren A. Physicochemical and biological properties of glutardialdehyde-stabilized heparin surfaces. Proceedings of the European Society for Artificial Organs 1975; 1: 11
  • 8 Gentry P. W, Alexander B. Specific coagulation factor adsorption to insoluble heparin. Biochemical & Biophysical Research Communication 1973; 50: 500
  • 9 Heideman M, Jacobsson B, Larsson R. Thromboresistance and stability of a heparinized polymer. Acta Radiologica (Diagnosis). 1976; 17: 877
  • 10 Jacobsson B, Schlossman D. Thrombogenic properties of heparinized vascular catheters. Acta Radiologica (Diagnosis) 1973; 14: 569
  • 11 Lagergren H. R, Eriksson J. C. Plastics with a stable surface monolayer of cross-linked heparin: Preparation and evaluation. Transactions of the American Society for Artificial Internal Organs 1971; 17: 10
  • 12 Lagergren H, Olsson P, Swedenborg J. Inhibited platelet adhesion: A non-thrombogenic characteristic of a heparin-coated surface. Surgery 1974; 75: 643
  • 13 Lee R. G, Adamson C, Kim S. W. Competitive adsorption of plasma proteins onto polymer surfaces. Thrombosis Research 1974; 4: 485
  • 14 Levy L, Petracek F. J. Chemical and pharmacological studies on N-resulfated heparin. Proceedings of the Society for Experimental Biology and Medicin 1962; 109: 901
  • 15 Limber G. K, Glenn C, Mason R. G. Studies of the proteins elutable from certain artificial surfaces exposed to human plasma. Thrombosis Research 1974; 5: 735
  • 16 Lowry O. H, Rosebourgh N. J, Farr A.L, Randall R. J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193: 265
  • 17 Lyman D. J, Knutson K, Shibatami K. The effects of chemical structure and surface properties of synthetic polymers on the coagulation of blood. IV. The relation between polymer morphology and protein adsorption. Transactions of the American Society for Artificial Internal Organs 1975; 21: 49
  • 18 Macintosh F. C. A colorimetric method for the standardization of heparin preparations. Biochemistry 1941; 35: 776
  • 19 Miller-Andersson M, Borg H, Andersson L. O. Purification of antithrombin III by affinity chromatography. Thrombosis Research 1974; 5: 439
  • 20 Olsson P, Lagergren H, Larsson R, Rådegran K. Prevention of platelet adhesion and aggregation by a glutardialdehyde stabilized heparin surface. Submitted to Thrombosis et Diathesis Haemorrhagica 1976
  • 21 Scott J. E. Aliphatic ammonium salts in the assay of acidic polysaccharides from tissues. Methods of Biochemical Analysis 1960; 8: 145
  • 22 Tanzawa H, Mori Y, Harumiya N, Miyama H, Hori M, Oshima N, Idezuki Y. Preparation and evaluation of a new athrombogenic heparinized polymer for use in cardiovascular system. Transactions of the American Society for Artificial Internal Organs 1973; 19: 188